CN101596249A - 治疗腹泻的中药组合物和中药药物及其制备方法 - Google Patents
治疗腹泻的中药组合物和中药药物及其制备方法 Download PDFInfo
- Publication number
- CN101596249A CN101596249A CNA2009101588236A CN200910158823A CN101596249A CN 101596249 A CN101596249 A CN 101596249A CN A2009101588236 A CNA2009101588236 A CN A2009101588236A CN 200910158823 A CN200910158823 A CN 200910158823A CN 101596249 A CN101596249 A CN 101596249A
- Authority
- CN
- China
- Prior art keywords
- medicine
- chinese medicine
- crude drug
- composition
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 186
- 239000000203 mixture Substances 0.000 title claims abstract description 88
- 238000002360 preparation method Methods 0.000 title claims description 36
- 230000000741 diarrhetic effect Effects 0.000 title claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 91
- 229940079593 drug Drugs 0.000 claims abstract description 51
- 239000000341 volatile oil Substances 0.000 claims abstract description 50
- 238000001556 precipitation Methods 0.000 claims abstract description 16
- 238000000605 extraction Methods 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 65
- 239000000843 powder Substances 0.000 claims description 33
- 238000004821 distillation Methods 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 26
- 239000012567 medical material Substances 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 25
- 208000019637 Infantile Diarrhea Diseases 0.000 claims description 22
- 239000002674 ointment Substances 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 13
- 238000004064 recycling Methods 0.000 claims description 13
- 239000000499 gel Substances 0.000 claims description 9
- -1 filter Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 6
- 229940040145 liniment Drugs 0.000 claims description 2
- 239000000865 liniment Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 21
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 description 37
- 238000003756 stirring Methods 0.000 description 22
- 239000006071 cream Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 230000037396 body weight Effects 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 12
- 241000283973 Oryctolagus cuniculus Species 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 8
- 229940012189 methyl orange Drugs 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 230000035617 depilation Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 230000030136 gastric emptying Effects 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- 239000008158 vegetable oil Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 229910052979 sodium sulfide Inorganic materials 0.000 description 5
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 5
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 4
- 239000003390 Chinese drug Substances 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000036592 analgesia Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 239000011505 plaster Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 244000203593 Piper nigrum Species 0.000 description 3
- 235000008184 Piper nigrum Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 206010048222 Xerosis Diseases 0.000 description 3
- 235000013614 black pepper Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 210000003746 feather Anatomy 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000000622 irritating effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 206010034754 petechiae Diseases 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241001062472 Stokellia anisodon Species 0.000 description 2
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 229960001259 diclofenac Drugs 0.000 description 2
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 2
- ILYCWAKSDCYMBB-OPCMSESCSA-N dihydrotachysterol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1/C[C@@H](O)CC[C@@H]1C ILYCWAKSDCYMBB-OPCMSESCSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000036391 respiratory frequency Effects 0.000 description 2
- 238000010074 rubber mixing Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 206010058679 Skin oedema Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241001078983 Tetradium ruticarpum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- STZCRXQWRGQSJD-UHFFFAOYSA-M sodium;4-[[4-(dimethylamino)phenyl]diazenyl]benzenesulfonate Chemical compound [Na+].C1=CC(N(C)C)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
级数 | 1 | 2 | 3 | 4 |
污迹直径(cm) | <1 | 1-1.9 | 2-3 | >3 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910158823.6A CN101596249B (zh) | 2009-07-08 | 2009-07-08 | 治疗腹泻的中药组合物和中药药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910158823.6A CN101596249B (zh) | 2009-07-08 | 2009-07-08 | 治疗腹泻的中药组合物和中药药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101596249A true CN101596249A (zh) | 2009-12-09 |
CN101596249B CN101596249B (zh) | 2014-05-14 |
Family
ID=41417967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910158823.6A Active CN101596249B (zh) | 2009-07-08 | 2009-07-08 | 治疗腹泻的中药组合物和中药药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101596249B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822799A (zh) * | 2010-05-26 | 2010-09-08 | 成都晟铭医药科技有限公司 | 用于治疗腹泻的中药组合物、制剂及其制备方法 |
CN101852790A (zh) * | 2010-05-26 | 2010-10-06 | 成都晟铭医药科技有限公司 | 一种胡椒碱含量的测定方法及其用途 |
CN103169825A (zh) * | 2012-11-28 | 2013-06-26 | 沈阳伟嘉牧业技术有限公司 | 一种用于治疗畜禽肠道疾病的药物 |
CN104547056A (zh) * | 2014-12-18 | 2015-04-29 | 南方医科大学 | 一种治疗小儿腹泻的外用脐部贴剂及其制备方法 |
CN105457013A (zh) * | 2015-12-09 | 2016-04-06 | 成都乾坤动物药业有限公司 | 一种治疗家畜腹泻的药物组合物及其制备方法 |
CN111632123A (zh) * | 2020-07-22 | 2020-09-08 | 陈海燕 | 一种健脾脐贴药剂 |
CN111700993A (zh) * | 2020-08-11 | 2020-09-25 | 河南中医药大学第一附属医院 | 治疗小儿泄泻的敷贴用的中药组合物及其制备方法和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1292770C (zh) * | 2004-01-06 | 2007-01-03 | 山西晋新双鹤药业有限责任公司 | 一种治疗小儿腹泻药物及其制法 |
-
2009
- 2009-07-08 CN CN200910158823.6A patent/CN101596249B/zh active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101822799A (zh) * | 2010-05-26 | 2010-09-08 | 成都晟铭医药科技有限公司 | 用于治疗腹泻的中药组合物、制剂及其制备方法 |
CN101852790A (zh) * | 2010-05-26 | 2010-10-06 | 成都晟铭医药科技有限公司 | 一种胡椒碱含量的测定方法及其用途 |
CN101822799B (zh) * | 2010-05-26 | 2012-07-25 | 成都晟铭医药科技有限公司 | 用于治疗腹泻的中药组合物、制剂及其制备方法 |
CN103169825A (zh) * | 2012-11-28 | 2013-06-26 | 沈阳伟嘉牧业技术有限公司 | 一种用于治疗畜禽肠道疾病的药物 |
CN104547056A (zh) * | 2014-12-18 | 2015-04-29 | 南方医科大学 | 一种治疗小儿腹泻的外用脐部贴剂及其制备方法 |
CN104547056B (zh) * | 2014-12-18 | 2017-08-22 | 南方医科大学 | 一种治疗小儿腹泻的外用脐部贴剂及其制备方法 |
CN105457013A (zh) * | 2015-12-09 | 2016-04-06 | 成都乾坤动物药业有限公司 | 一种治疗家畜腹泻的药物组合物及其制备方法 |
CN105457013B (zh) * | 2015-12-09 | 2019-08-16 | 成都乾坤动物药业有限公司 | 一种治疗家畜腹泻的药物组合物及其制备方法 |
CN111632123A (zh) * | 2020-07-22 | 2020-09-08 | 陈海燕 | 一种健脾脐贴药剂 |
CN111700993A (zh) * | 2020-08-11 | 2020-09-25 | 河南中医药大学第一附属医院 | 治疗小儿泄泻的敷贴用的中药组合物及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101596249B (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101596249B (zh) | 治疗腹泻的中药组合物和中药药物及其制备方法 | |
CN102836228B (zh) | 一种治疗结膜炎的中药组合物及其制备方法和应用 | |
CN103263531B (zh) | 一种治疗三叉神经痛的中药组合物及其制备方法 | |
CN103272092A (zh) | 一种藿香正气外用制剂及其制备方法与用途 | |
CN105194341B (zh) | 治疗头颈部肿瘤放疗后口干症的药物 | |
CN101991811B (zh) | 一种治疗风湿关节疼痛、感冒头痛、脘腹疼痛、冻疮的中药组合物及其制备方法 | |
CN102258742A (zh) | 一种治疗抑郁症的中药组合物及其制备方法 | |
CN111214637A (zh) | 一种中药组合物及其制备方法和药用用途 | |
CN101590126B (zh) | 一种治疗良性***增生的中药复方 | |
CN101757053A (zh) | 黄蜀葵花有效部位——总黄酮提取物的制备工艺及新用途 | |
CN105326954B (zh) | 一种治疗睑缘炎的中药组合物及其制备方法 | |
CN106038877A (zh) | 治疗儿童化脓性中耳炎的药物组合物及其制备方法 | |
CN105343274A (zh) | 一种具有消炎止咳作用的药物组合物 | |
CN101120969A (zh) | 一种治疗糖尿病及其并发症的药物及其制备方法 | |
CN100998744A (zh) | 一种治疗小儿多动症的中成药 | |
JP5265347B2 (ja) | 急性および慢性気管支炎を治療するための医薬を調合する際の魔芋(こんにゃく芋)およびその抽出物の利用 | |
CN104622987B (zh) | 一种治疗慢性肝炎肝硬化的药物组合物及应用 | |
CN105687278A (zh) | 治疗中晚期肺癌的药物组合物 | |
CN100591343C (zh) | 治疗肺癌的药物及其制备工艺 | |
CN106727859A (zh) | 一种治疗咽炎的药物组合物及其制备方法 | |
CN104689073A (zh) | 用于治疗阴虚毒热型肺癌的药物及其制备方法 | |
CN102058848A (zh) | 一种藏药组合物在制备治疗中枢神经性疼痛药物中的应用 | |
CN113181277A (zh) | 一种治疗便秘的中药组合物及其应用 | |
CN103877506A (zh) | 一种治疗癫痫病的药物 | |
CN101843689B (zh) | 一种治疗更年期综合征的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HENGKANG MEDICAL GROUP CO., LTD. Free format text: FORMER OWNER: CHENGDU SHENGMING PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20140613 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610000 CHENGDU, SICHUAN PROVINCE TO: 746500 LONGNAN, GANSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140613 Address after: 746500 Gansu city of Longnan Province Wang Kang dam Duyiwei Industrial Park Patentee after: HENGKANG MEDICAL GROUP CO.,LTD. Address before: 610000 Building 1, high tech incubator Park, South Tianfu Road, Tianfu Road, Chengdu hi tech Zone, Sichuan Patentee before: CHENGDU SHENGMING PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 746500 Wang Yi Industrial Park, Wang Ba, Kang County, Longnan, Gansu Patentee after: New Journey Health Technology Group Co.,Ltd. Address before: 746500 Wang Yi Industrial Park, Wang Ba, Kang County, Longnan, Gansu Patentee before: HENGKANG MEDICAL GROUP CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder |